Evidence Hub

Immunoglobulin A nephropathy in remission: a case report

A. Mahat, N. Lageju, Durga Neupane, U. Mishra, Sefali Koirala

Annals of Medicine and Surgery, 2023

1 citation

Abstract

Introduction: Immunoglobulin A nephropathy is the most prevalent form of primary glomerulonephritis. Case presentation: A 33-year-old military male presented with complaints of fever, headache, myalgia, chills, and haematuria for 10 years. His lab results showed elevated serum creatinine levels and proteinuria. A renal biopsy was done which was consistent with a diagnosis of immunoglobulin A nephropathy. He was managed with antihypertensive, including angiotensin-converting enzyme inhibitors, steroids and immunosuppressants, and Omega-3 fatty acids. There was remission of the symptoms and the patient’s serum creatinine and sonogram findings returned to baseline. Conclusion: Routine follow-up along with the appropriate use of medications can limit disease complications and progression.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free